Clinical Trial Update: Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating immunologic and virologic responses during analytical treatment interruption after combination b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 1 | Status: ENROLLING_BY_INVITATION